Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use Didanosine Delayed-Release Capsules Enteric-Coated Pellets safely and effectively. See full prescribing information for Didanosine Delayed-Release Capsules Enteric-Coated Pellets. Initial U.S. Approval: 1991
Medication labelWhy this: Advisory · dailymed-prescription
Didanosine delayed-release capsules, also known as ddI, in combination with other antiretroviral agents is indicated for the treatment of human immunodeficiency virus (HIV)-1 infection [see Clinical Studies (14)].
- generic_name
- didanosine
- product_names
- Didanosine
- ndc
- 53808-0236, 0555-0589, 53808-0236-1, 53808-0353, 0555-0590, 53808-0353-1
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en